Key words: adhesion molecule; biocompatibility; calcium; citrate; cuprophane; haemodialysis Background. Citrate, used for the anticoagulation of the extracorporeal dialysis circuit, reduces ionized calcium by chelation and has been claimed to attenuate dialyser membrane bioincompatibility. Dialysis with Introduction complement-activating cuprophane membranes is associated with leukopenia which has been related to an Locoregional citrate anticoagulation has been proincrease in adhesion molecule expression on the surface posed as a treatment for haemodialysis patients who, of circulating leukocytes.
The degree of anticoagulation obtained by citrate was dialysate composition are introduced. The aim of the monitored by measuring ACT in the inlet blood line present study was to determine the effect of citrate (upstream the citrate infusion) and in the outlet blood line dialysis on the expression of surface molecules, using (downstream the dialyser and upstream the CaCl 2 infusion).
citrate at physiologically acceptable concentrations.
Ionized calcium, sodium and pH were measured in blood collected from the inlet line: blood samples were drawn into syringes containing heparin (Ciba Corning, Rapidlyte@ arter-
Patients and methods
ial blood sampler), transported on ice and immediately analysed on a Ciba Corning 288 blood gas system (Ciba
Patients
Corning Diagnostics Corp, Medfield, MA, USA). Citrate and calcium chloride infusion rates were adjusted to the This study was undertaken in 14 well-equilibrated patients outlet ACT and inlet ionized calcium; an outlet ACT between on maintenance haemodialysis (6 men, 8 women, mean age: 180 and 250 s was sought; the inlet ionized calcium concentra-70±12 years) with a mean body weight of 71.5±17.9 kg. tion was targeted between its starting value and 0.9 mmol/l. The patients had no infections and had not received antibiotic Only minor adaptations were necessary. or immunosuppressive treatment for at least 3 months preceding the study. Patients suffering from auto-immune disorders were excluded. Informed consent was obtained from all Leukocyte counting and expression of surface molecules patients. Causes of end-stage renal disease included diabetic nephropathy (n=2), chronic glomerulonephritis (n=1), Sample collection. At the start of dialysis and before heparin chronic interstitial nephritis (n=6) and renovascular disease or citrate administration, blood was collected into EDTA (n=5). Parenteral nutrition, iron or mannitol were not tubes. At 15, 60 and 180 min of dialysis, blood samples were administered during the study. All patients received erythro-drawn from the inlet blood line, upstream of the citrate or poietin to maintain a haematocrit of ±33%. Before the start heparin infusion port. Blood samples were processed of the study, all patients underwent conventional haemodia-immediately. lysis with a low-flux polysulfone membrane (Rapido BLS Analytical techniques. Total leukocyte number was counted 643, 1.36 m2, Sorin Biomedica Bellco, Mirandola, Italy or in each sample using a Coulter CounterA M530 (Coulter F8, 1.8 m2, Fresenius, Bad Homburg, Germany) three times Electronics Ltd, Bedfordshire, UK ). Cell differentiation was a week for either 4 or 4.5 h per session.
based on light scatter using a flow cytometer [FACScan@ In all patients, two consecutive dialysis sessions were (Becton Dickinson, San Jose, CA, USA)]; lymphocytes, studied; both were performed with a low flux cuprophane granulocytes and monocytes were selectively gated by low membrane (Spiraflo NT 1375, 1.35 mO, Sorin Biomedica forward-angle light scatter, which is a measure of cell size, Bellco, Mirandola, Italy). In a random order, either standard and by 90°light scatter, which is a measure of granularity. heparin or locoregional citrate anticoagulant was used. The expression of CD45, CD11b and CD11c on granulocytes Approval of the local ethical committee was obtained.
and of CD14 on monocytes was evaluated flow cytometrically by direct immunofluorescence. Leukocytes were studied in the 'baseline state', without extra ex vivo stimulation, as well
Haemodialysis and anticoagulation
as after ex vivo stimulation with PMA or with fMLP. For this purpose, PMA (Sigma, St Louis, MO, USA) was disDuring each experimental dialysis session, blood flow, dialysate flow and dialysate temperature were maintained at solved in dimethylsulphoxide (DMSO, Sigma) to obtain a stock solution (1 mg/ml ). Before the experiment, the latter 200 ml/min, 500 ml/min and 37°C respectively.
Haemodialysis with heparin anticoagulation was per-solution was immediately diluted 1/100 in sodium acetate buffer. One hundred microlitres of this PMA-solution were formed according to standard procedures with a starting dose of 2000 IU, followed by a continuous infusion of added to 500 ml whole blood to a final concentration of 1.7 mg/ml. fMLP (Sigma) was dissolved in DMSO to obtain 1932±578 IU/h. The degree of anticoagulation obtained by heparin was monitored by measuring activated clotting time a stock solution of 5 mg/ml, which was diluted 1/2000 in sodium acetate buffer immediately before the experiment. (ACT, HemochronA 801, International Technidyne Corporation, Edison, NJ, USA). The normal range of ACT Ten microlitres of this fMLP-solution were added to 500 ml whole blood (final concentration of 49 ng/ml ). Samples were is 105-167 s. The ACT obtained at inlet blood line of the dialyser was targeted at >150 s. incubated for 10 min at 37°C. The expression of surface molecules on leukocytes, was A standard dialysate composition was used: bicarbonate 38.5 mmol/l, sodium 138 mmol/l, chloride 104 mmol/l, acetate measured using the following monoclonal antibodies (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA): 4 mmol/l, calcium 1.25 mmol/l and magnesium 0.5 mmol/l. The dialysate potassium concentration was adapted to the needs of (i) phycoerythrin (PE) conjugated anti-CD11b (Leu@-15),
(ii) PE conjugated anti-CD11c (Leu@-M5), or (iii) a mixture the individual (range: 1-3 mmol/l ). Routine control of dialysate bacterial content revealed <5 CFU/ml. of fluorescein isothiocyanate (FITC ) conjugated anti-CD45 (Anti-Hle-1) together with PE conjugated anti-CD14 Citrate anticoagulation was performed with a calcium-free dialysate; all other dialysate constituents were present in (Leu@-M3) (Simultest@, LeucoGATE@). Twenty microlitres of these antibodies were then placed into FalconA polystyrene concentrations identical to those in the heparin sessions. Trisodium citrate at 1.2 mol/l (Sterop SA, Brussels, Belgium) test tubes (Becton Dickinson Labware, Lincoln Park, NJ, USA), to which 100 ml of whole blood were added. After was infused into the inlet blood line of the dialyser at a starting rate of 43 ml/h, corresponding to 4.3 mmol citrate mixing at low speed, the samples were incubated with the respective monoclonal antibodies for 20 min at 4°C in the per litre of blood passing through the extracorporeal circuit. In order to restore the calcium concentrations in the blood dark. FACSA Lysing Solution, 2 ml, diluted 10×, was added to each tube, followed by incubation for 8 min. After washing before returning to the patient, calcium chloride [1 g CaCl 2 .4 aq, (Ca2+ 11 meq), aqua ad 10 ml, Sterop] was infused in the cells twice with Dulbecco's phosphate-buffered saline (GIBCO BRL Life Technologies, Paisley, UK ), the cell pellet the outlet blood line, at a starting rate of 20 ml/h. A. Dhondt et al. 1754 was resuspended in Hanks' balanced salt solution (GIBCO No systemic anticoagulation occurred during citrate BRL), and immediately analysed on a FACScan@. Data on administration as inlet ACT remained within the 10 000 cells were collected in list mode files, the detector normal range with a mean of 121±18 s at t 0 , 119±24 threshold being held on FSC-H:200. FacsFlow@ was used as at t 60 , 106±19 at t 120 and 115±31 at t 180 .
sheath fluid. CaliBRITE@ Beads and AutoCOMP@ Software were applied for setting photomultiplier tube voltages,
Leukocyte counts
adjusting fluorescence compensation and checking detector sensitivity. The mean channel of fluorescence intensity was Figure 1 shows the evolution of the peripheral granulomeasured.
cyte (A) and monocyte (B) counts during the two Antibodies were used in saturating concentrations. Non-dialysis sessions. With both heparin and citrate, a Table 1 . nounced that fluorescence intensity became too high to be The increase of expression of CD45, CD11b and measured correctly. Therefore, activation of CD11b was only CD11c after stimulation with PMA or fMLP, is disstudied with fMLP.
played in Table 2 . The expression of CD14 on monoData are expressed as means±standard deviation (SD), cytes is shown in The 'baseline state' expression of CD45 on granulocytes is displayed in Figure 2A and Table 1A cytes is displayed in Figure 2B and 
CD11c expression on granulocytes
enia induced by cuprophane dialysis with a nadir at 15 min, was profound with both anticoagulation regiThe 'baseline state' expression of CD11c on granulo-mens; (ii) the 'baseline state' expression of CD45, cytes is displayed in Figure 2C and Table 1C for both CD11b and CD11c on granulocytes showed a similar heparin and citrate. The evolution paralleled the results increase during cuprophane dialysis with a peak value observed with CD45 and CD11b. During heparin at 15 min, irrespective of the anticoagulation regimen; dialysis 'baseline state' CD11c expression increased (iii) delta-PMA and delta-fMLP for CD45 and CD11c from 148±57 at t 0 to 264±47 at t 15 (P∏0.01 vs t 0 ) (granulocytes) and for CD14 (monocytes), were supand remained elevated at t 60 and t 180 with values of pressed during cuprophane dialysis, but again to a 216±36 and 202±34 respectively (P∏0.01 vs t 0 ). A similar extent with both heparin and citrate. It is similar increase was observed during citrate dialysis concluded that no significant differences in leukocyte from 183±55 at t 0 to 244±61 at t 15 (P∏0.01 vs t 0 ), surface molecule expression were observed between 224±41 at t 60 and 206±29 at t 180 (P∏0.05 vs t 0 ). heparin and citrate. ANOVA revealed no differences between heparin and It has repeatedly been demonstrated that cuprocitrate.
phane haemodialysis is associated with leukopenia, The evolution of delta-PMA and delta-fMLP CD11c complement activation and an up-regulation of granexpression is detailed in Table 2C . A substantial ulocyte surface molecules such as CD11b [8] [9] [10] [11] , decrease was observed in delta-PMA vs t 0 during both CD11c [10, 12] and CD45 [11, 13, 14] , CD11b and heparin and citrate dialysis. No differences were CD11c being adhesion molecules. There is a striking observed between heparin and citrate. Delta-fMLP parallelism in the timing of these phenomena, sugalso showed a pronounced decrease during cuprophane gesting a causal relationship: the up-regulation of dialysis with both heparin and citrate. Again, no leukocyte adhesion molecules is considered to be a significant differences were observed between heparin consequence of complement activation and leads to an and citrate.
increased adhesion of circulating leukocytes to the vascular endothelium, resulting in sequestration and CD14 expression on monocytes leukopenia. In addition, in vivo and in vitro experiments demonstrated an up-regulation of CD11b/CD18 after The expression of CD14 on monocytes during heparin injection of C5a [15] or incubation with C5a [8, 9, 16 ] . and citrate dialysis is summarized in Table 3 . After an Also, in the present study, dialysis with the complement initial decrease in 'baseline state' CD14 expression activating cuprophane membrane resulted in an during both heparin and citrate dialysis at t 15 and t 60 , up-regulation of the 'baseline' expression of CD45, the CD14 expression rose again to reach a slightly CD11b and CD11c (Figure 2) . increased value at the end of the session. No significant
The up-regulation of surface molecules on leukocytes differences were observed between heparin and citrate during dialysis has been attributed to the recruitment dialysis.
to the cell surface of already synthesized molecules A marked decrease was observed in delta-PMA vs stored in intracellular granules. This theory is based t 0 during cuprophane dialysis with both heparin and on the rapidity of the up-regulation, which cannot be citrate. After 15 min of heparin dialysis delta-PMA accomplished in the same time frame by protein syndecreased and remained suppressed during the whole thesis. Moreover, in vitro up-regulation was not inhibdialysis session (P∏0.01 vs t 0 for each time point). ited by protein synthesis inhibitors [17] . Storage in After 15 min of citrate dialysis a non-significant specific granules has been demonstrated for CD11b decrease in delta-PMA was observed; this parameter [18] . was significantly suppressed at the other time points:
There are at least two mechanisms whereby citrate P∏0.05 vs t 0 for t 60 and t 180 . ANOVA revealed no anticoagulation might influence the expression of surdifferences between heparin and citrate.
face molecules: (i) inhibition of degranulation by Delta-fMLP showed a decrease during cuprophane lowering the calcium concentration in the extracorpordialysis vs t 0 , with both heparin and citrate. No signieal circuit, and (ii) attenuation of complement activaficant differences were observed between the two antiction by lowering the calcium (classical pathway) and oagulation regimens. magnesium (alternate pathway) concentrations. Leukocyte degranulation is calcium dependent as it
Discussion
can be inhibited by lowering extracellular ionized calcium in vitro [19, 20] and in vivo [2] . The depletion of ionized calcium within the artificial kidney, due to In the present study we evaluated the expression of the surface molecules CD45, CD11b and CD11c on complexation by citrate and the use of calcium-free dialysate, could inhibit the degranulation of leukocytes circulating granulocytes and of CD14 on monocytes, during cuprophane dialysis, with different anticoagul-and the up-regulation of surface molecules. A blunted up-regulation of CD11b/CD18 and CD45 was ation regimens, comparing heparin with citrate. The evolution of this expression was studied, either on observed in in vitro experiments, after fMLP stimulation, when calcium was depleted [21, 22] . leukocytes which were not submitted to ex vivo stimulation ('baseline state'), or on PMA-or fMLP-activated
The second mechanism whereby citrate could act, is the blunting of complement activation. The main route leukocytes. The main conclusions are: (i) leukocytop-of complement activation in cuprophane haemodialysis
The leukocyte surface molecules evaluated in the present study, play a pathophysiological role in the is through the alternate pathway [4, 23] , which is magnesium dependent. It is well known that citrate defence mechanisms against infection. CD11b and CD11c (alpha subunits), associated non-covalently complexes not only calcium but also magnesium. In addition, ionized calcium is required for the stabiliza-with CD18 (beta subunit), are leukocyte integrins.
Numerous physiological functions have been ascribed tion of the C1 complex (C1q-C11r-C1s) in the classical pathway. At least two studies suggest that the classical to these integrins, including activation of neutrophils and monocytes and enhancement of adhesion, transmipathway is also involved in intradialytic complement activation [16, 24] . Whatever the mechanism, an gration and phagocytosis [29] . The importance of this integrin subfamily is illustrated by the severe infections attenuation of complement activation can be expected with citrate, and has been demonstrated during haemo-that develop in patients with a congenital deficiency of leukocyte integrins. dialysis [2,3] as well as during plasma exchange procedures [25, 26 ] .
CD45 leukocyte common antigen is a glycoprotein expressed on the cell surface of all nucleated haematoIn spite of the theoretical benefit of citrate, the present study was not able to demonstrate a reduced poietic cells. Its intracellular domain has a tyrosine phosphatase activity and plays a role in signal transleukopenia or blunted up-regulation of surface molecules. Citrate can be administered at different concentra-duction and modulation. Besides its numerous actions on lymphocytes, CD45 on granulocytes interacts with tions. Data in the literature suggest that high citrate concentrations (>7.4 mmol/l ) may be associated with leukotriene B 4 and C5a receptor-associated molecules and regulates chemotactic response [30] . a blunted leukopenia [1,2,7] in contrast to low citrate concentrations [3, 5, 6 ]. It could be hypothesized that CD14 is a glycosylphosphatidylinositol-anchored glycoprotein, expressed chiefly on monocytes and high citrate concentrations give rise to lower ionized calcium concentrations and that, in the present study, macrophages. CD14 functions as a receptor for bacterial lipopolysaccharides (LPS). It transduces activathis ionized calcium might be lowered insufficiently within the dialyser to block leukocyte degranulation. tion signals for the production of tumour necrosis factor-alpha ( TNF-a), IL-6 and IL-8 [31], and plays However, the blood calcium concentration was apparently low enough to inhibit blood coagulation. In a pivotal role in the immunological reaction against bacterial infection and in sepsis. addition, during a number of citrate dialysis sessions, the ionized calcium in the outlet blood line, proximal
In conclusion, despite its theoretical benefits, no correction of the bioincompatibility phenomena, as to the CaCl 2 infusion, was determined and found to be immeasurably low (detection limit 0.2 mmol/l, data measured by leukocyte count and expression of leukocyte surface molecules was obtained when citrate anticnot shown).
Another possible explanation is that degranulation oagulation was used in a concentration of 4.3 mmol/l. It was the aim of the present study to determine the could occur in spite of low calcium concentration depending on the type and strength of the activating effect of citrate dialysis on the expression of surface molecules, using citrate at concentrations without stimulus. This hypothesis is supported by a study demonstrating that calcium depletion did not blunt in potential for electrolyte disturbances. Further study with different dosages of citrate should be considered vitro CD11b/CD18 up-regulation after LPS stimulation, whereas it did blunt the up-regulation observed in the future. after fMLP [22] . Complement suppression by citrate is incomplete [2, 3] , so that the threshold value for induction of the surface molecule expression might still References be attained. 
